TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
-5.03%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$1.81B
AUM Growth
+$1.81B
(+20%)
Cap. Flow
+$415M
Cap. Flow
% of AUM
22.93%
Top 10 Holdings %
Top 10 Hldgs %
39.2%
Holding
208
New
25
Increased
77
Reduced
32
Closed
6
Top Buys
| 1 |
Dynavax Technologies
DVAX
|
$50.6M |
| 2 |
Galapagos
GLPG
|
$45.2M |
| 3 |
Kiniksa Pharmaceuticals
KNSA
|
$33.1M |
| 4 |
Spyre Therapeutics
SYRE
|
$33.1M |
| 5 |
SLRN
ACELYRIN
SLRN
|
$24.3M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$10.6M |
| 2 |
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
|
$7.23M |
| 3 |
GRAL
GRAIL, Inc. Common Stock
GRAL
|
$4.82M |
| 4 |
ALMS
Alumis Inc. Common Stock
ALMS
|
$4.72M |
| 5 |
Seer Inc
SEER
|
$1.52M |
Sector Composition
| 1 | Healthcare | 94.79% |
| 2 | Technology | 1.25% |
| 3 | Communication Services | 1.23% |
| 4 | Consumer Discretionary | 0.99% |
| 5 | Financials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AstraZeneca
AZN
$255B
| $18.4M | 1.02% |
250,000
+100,000
| +67% | +$7.35M |
|
27
Liquidia Corp
LQDA
$2.52B
| $17.7M | 0.98% |
1,200,000
+100,000
| +9% | +$1.48M |
|
28
Neurocrine Biosciences
NBIX
$13.5B
| $16.6M | 0.92% |
150,000
| – | – |
|
|
AVDL
29
Avadel Pharmaceuticals
AVDL
$1.42B
| $16.4M | 0.91% |
2,097,500
+600,000
| +40% | +$4.7M |
|
|
ITOS
30
DELISTED
iTeos Therapeutics
ITOS
| $16.1M | 0.89% |
2,689,200
+2,467,484
| +1,113% | +$14.7M |
|
31
Meta Platforms (Facebook)
META
$1.85T
| $15.9M | 0.88% |
27,575
+975
| +4% | +$562K |
|
32
GSK
GSK
$79.3B
| $15.5M | 0.86% |
400,000
| – | – |
|
33
NVIDIA
NVDA
$4.15T
| $15.5M | 0.85% |
142,569
| – | – |
|
34
Sanofi
SNY
$122B
| $15M | 0.83% |
270,000
| – | – |
|
35
Atea Pharmaceuticals
AVIR
$275M
| $14.4M | 0.79% |
4,800,000
+11,088
| +0.2% | +$33.2K |
|
36
Altimmune
ALT
$325M
| $13.8M | 0.76% |
2,750,000
| – | – |
|
37
Zymeworks
ZYME
$1.07B
| $13.1M | 0.72% |
1,100,000
| – | – |
|
38
Nkarta
NKTX
$149M
| $13M | 0.72% |
7,055,576
+4,761,857
| +208% | +$8.76M |
|
|
CRGX
39
DELISTED
CARGO Therapeutics
CRGX
| $12.5M | 0.69% |
3,059,630
+2,419,630
| +378% | +$9.85M |
|
|
CYBN
40
Cybin
CYBN
$142M
| $11.6M | 0.64% |
1,830,097
+500,000
| +38% | +$3.17M |
|
41
Vaxcyte
PCVX
$4.17B
| $11.3M | 0.63% |
300,000
| – | – |
|
42
Keros Therapeutics
KROS
$640M
| $11.2M | 0.62% |
+1,100,000
| New | +$11.2M |
|
43
Teladoc Health
TDOC
$1.37B
| $11.1M | 0.62% |
1,400,000
| – | – |
|
44
Journey Medical
DERM
$169M
| $10.9M | 0.61% |
1,854,596
+129,027
| +7% | +$761K |
|
45
Vanda Pharmaceuticals
VNDA
$279M
| $10.8M | 0.6% |
2,353,307
| – | – |
|
|
ONC
46
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $10.1M | 0.56% |
37,000
| – | – |
|
47
Arvinas
ARVN
$580M
| $9.78M | 0.54% |
+1,393,800
| New | +$9.78M |
|
48
Harmony Biosciences
HRMY
$2.16B
| $9.33M | 0.52% |
281,200
| – | – |
|
49
Alibaba
BABA
$325B
| $9.26M | 0.51% |
+70,000
| New | +$9.26M |
|
50
CRISPR Therapeutics
CRSP
$4.82B
| $9.07M | 0.5% |
266,500
| – | – |
|